Skip to content

Clinical trials

Phase 2 Narcolepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Narcolepsy Phase: Phase 2 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20101
20111
20121
20162
20171
20193
20212
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jazz Pharmaceuticals3
Alkermes, Inc.2
NLS Pharmaceutics2
Alza Corporation, DE, USA1
Axsome Therapeutics, Inc.1
Centessa Pharmaceuticals (UK) Limited1
Eisai Inc.1
Emory University1
GlaxoSmithKline1
Lynn Marie Trotti1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Narcolepsy20
Disorders of Excessive Somnolence8
Cataplexy3
Idiopathic Hypersomnia3
Sleep Wake Disorders1
Sleepiness1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.